Lexatumumab
WikiDoc Resources for Lexatumumab |
Articles |
---|
Most recent articles on Lexatumumab Most cited articles on Lexatumumab |
Media |
Powerpoint slides on Lexatumumab |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Lexatumumab at Clinical Trials.gov Clinical Trials on Lexatumumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Lexatumumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Lexatumumab Discussion groups on Lexatumumab Patient Handouts on Lexatumumab Directions to Hospitals Treating Lexatumumab Risk calculators and risk factors for Lexatumumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Lexatumumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Lexatumumab (also known as ETR2-ST01) is a human monoclonal antibody used to treat cancer.